Strategic partnerships CEPI grant support and recent global collaborations indicate a strong appetite for deploying Alveo's portable molecular diagnostics in vaccine manufacturing, animal health, and human surveillance. Target potential partners in global health consortia, vaccine producers, and government programs seeking rapid, on-site pathogen detection solutions.

Animal health expansion Launch of Avian Influenza test and collaboration with Global Animal Health signals a growing revenue line in veterinary diagnostics. Proactively pursue large poultry producers, integrators, and regional veterinary networks with demand for decentralized, rapid testing across farms and supply chains.

Clinical readiness Ongoing CDC and human avian influenza initiatives suggest opportunities in clinical and public health settings for point-of-need diagnostics. Explore hospital systems, clinics, and specialty labs that require fast, multiplexed detection to improve outbreak response and patient flow.

Manufacturing tie‑ins Alveo’s platform is positioned to support manufacturing quality control and biosurveillance. Engage with pharmaceutical and biotech manufacturers seeking real-time pathogen monitoring to safeguard production lines and ensure continuity of supply.

Global scale access Global deployments and on-the-ground utility imply demand from emerging markets and multi‑national distributors. Focus on regional distributors, government programs, and NGO networks that need portable, affordable diagnostics to extend reach beyond centralized labs.